These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33805553)

  • 21. Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans.
    Yu H; Xia F; Lam KS; Wang Y; Bao Y; Zhang J; Gu Y; Zhou P; Lu J; Jia W; Xu A
    Clin Chem; 2011 May; 57(5):691-700. PubMed ID: 21325103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Osteonectin and Adipokine Profiles in Relation to Metabolically Healthy Obesity in Chinese Children: Findings From BCAMS.
    Fu J; Li Y; Esangbedo IC; Li G; Feng D; Li L; Xu L; Han L; Li M; Li C; Gao S; Li M; Willi SM
    J Am Heart Assoc; 2018 Dec; 7(23):e009169. PubMed ID: 30571596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
    Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
    Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin and Chemerin: Contrary Adipokines in Regulating Reproduction and Metabolic Disorders.
    Singh A; Choubey M; Bora P; Krishna A
    Reprod Sci; 2018 Oct; 25(10):1462-1473. PubMed ID: 29669464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of fibroblast growth factor 21 to meal intake and insulin infusion in patients on maintenance haemodialysis.
    Reinhard M; Frystyk J; Jespersen B; Randers E; Bibby BM; Ivarsen P
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):187-95. PubMed ID: 25659979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension.
    Huang Z; Xu A; Cheung BMY
    Curr Hypertens Rep; 2017 Apr; 19(4):28. PubMed ID: 28337713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Determination of Serum Levels of Diabetes-Associated Adipokines.
    Schleinitz D
    Rev Diabet Stud; 2015; 12(3-4):277-98. PubMed ID: 26859657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats.
    Tanajak P; Sa-Nguanmoo P; Wang X; Liang G; Li X; Jiang C; Chattipakorn SC; Chattipakorn N
    Acta Physiol (Oxf); 2016 Aug; 217(4):287-99. PubMed ID: 27119620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and expression patterns of adipokine genes during adipocyte differentiation in the Tibetan goat (Capra hircus).
    Li X; Wang Y; Guo J; Zhong T; Li L; Zhang H; Wang L
    Gene; 2018 Feb; 643():17-25. PubMed ID: 29197590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Food craving as a mediator between addictive-like eating and problematic eating outcomes.
    Joyner MA; Gearhardt AN; White MA
    Eat Behav; 2015 Dec; 19():98-101. PubMed ID: 26262570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans.
    Kralisch S; Tönjes A; Krause K; Richter J; Lossner U; Kovacs P; Ebert T; Blüher M; Stumvoll M; Fasshauer M
    J Endocrinol; 2013 Feb; 216(2):135-43. PubMed ID: 23129782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
    Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
    Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GCN2 and FGF21 are likely mediators of the protection from cancer, autoimmunity, obesity, and diabetes afforded by vegan diets.
    McCarty MF
    Med Hypotheses; 2014 Sep; 83(3):365-71. PubMed ID: 25015767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.
    Dostálová I; Kaválková P; Haluzíková D; Lacinová Z; Mráz M; Papezová H; Haluzík M
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3627-32. PubMed ID: 18559909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levothyroxine treatment restored the decreased circulating fibroblast growth factor 21 levels in patients with hypothyroidism.
    Wang G; Liu J; Yang N; Hu Y; Zhang H; Miao L; Yao Z; Xu Y
    Eur J Intern Med; 2016 Jun; 31():94-8. PubMed ID: 27085392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
    Woo YC; Xu A; Wang Y; Lam KS
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.